A Randomized Controlled Double-Blind Trial for Prevention of Recurrent Ischemic Priapism in Men With Sickle Cell Disease: A Pilot Study

Condition:   Priapism Due to Sickle Cell Disease Interventions:   Drug: Tadalafil;   Drug: Hydroxyurea;   Drug: Placebo Sponsor:   Vanderbilt University Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials